Posts

Showing posts from February, 2022

Long-term COVID symptom: This skin sensation can last for months.

Image
The World Health Organization (WHO) emphasised last week that long COVID hazards are real, and that such difficulties will be a part of our future regardless of the variation one has been infected with. More details about the symptoms and severity of the disease are emerging as more research is undertaken on the subject. According to recent studies, post-COVID sequelae increase the risk of heart disease, vasculitis, and other serious disorders. Aside from the more well-known symptoms of brain fog, shortness of breath, and loss of smell and taste, many patients are also reporting skin problems that should be taken seriously. What are the signs and symptoms of long-term COVID on the skin?  Many people who have been infected with COVID have reported a tingling feeling on their skin after they have recovered. If they have been sitting in the same position for a long time, such patients report prickling, tingling, or numbness. The sensations in the hands, arms, legs, and feet are intense. P

Omicron and Delta variants are neutralised by a booster dose of Covaxin vaccine candidate.

Image
Background :   Covaxin (BBV152) is an inactivated whole virion vaccine that produces strong antibodies and cell-mediated immunological memory responses against SARS-CoV-2. Covaxin is safe, well-tolerated, and effective against symptomatic and severe symptomatic SARS-CoV-2 infection in adults, with efficacy rates of 77.8% and 93.4 percent, respectively. Sera samples from Covaxin vaccinees have been shown to effectively neutralise the SARS-CoV-2 Alpha, Beta, Delta, Zeta, and Kappa variants in previous research. However, the recent appearance of the SARS-CoV-2 Omicron variant, which has over 30 mutations in its spike (S) region, has been linked to an increase in breakthrough infection rates in people who have had both primary and booster vaccinations. Lower neutralising responses of vaccine-induced anti-Omicron antibodies may be linked to an increased risk of symptomatic SARS-CoV-2 infection, illness severity, and COVID-19-related hospitalisation. Taken together, there isn't enough in